Ovagen 20mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

Ovagen 20mg             

Ovagen is a synthetic ultra-short peptide bioregulator composed of the amino acid sequence Glu-Asp-Leu (EDL). It belongs to the family of Khavinson peptide bioregulators, a class of tissue-specific peptides originally developed through research at the St. Petersburg Institute of Bioregulation and Gerontology. Ovagen has primarily been investigated for its potential role in liver biology, gastrointestinal physiology, cellular regeneration, and age-related tissue maintenance. While some commercial sources have associated the peptide with ovarian research, the majority of published descriptions position Ovagen as a liver- and gastrointestinal-targeted peptide bioregulator.

As an ultra-short peptide consisting of only three amino acids, Ovagen is being investigated for its proposed ability to influence gene expression through epigenetic regulation. Within the Khavinson bioregulator framework, short peptides are hypothesized to enter cells, interact with chromatin-associated proteins, and modulate tissue-specific gene transcription involved in cellular maintenance, protein synthesis, and regeneration. Although these mechanisms remain largely preclinical and require further independent validation, Ovagen continues to serve as an important investigational compound in peptide bioregulation research.

One of the primary areas of scientific investigation involves hepatocyte biology and liver regeneration. Experimental models have explored how Ovagen may influence cellular repair mechanisms, antioxidant responses, protein synthesis, and hepatic tissue homeostasis under conditions of oxidative stress and metabolic challenge. Researchers continue to study how short peptide bioregulators contribute to maintaining liver function during aging and cellular stress, although evidence specific to Ovagen remains limited and is largely derived from the broader Khavinson peptide research program.

Ovagen has also attracted attention in studies involving gastrointestinal epithelial biology. Laboratory investigations have explored its potential influence on intestinal epithelial maintenance, mucosal integrity, and digestive tissue regeneration. Scientists continue to investigate how peptide-mediated regulation of cellular signaling may contribute to preserving gastrointestinal barrier function and tissue homeostasis in experimental models.

Beyond liver and gastrointestinal research, Ovagen is being investigated in studies involving healthy aging, oxidative stress, mitochondrial biology, inflammatory signaling, and peptide-mediated genomic regulation. Researchers continue to evaluate how ultra-short peptides influence intracellular communication, chromatin organization, and adaptive cellular responses. Although promising mechanistic hypotheses exist, Ovagen remains a research compound with no approved therapeutic applications, and high-quality human clinical evidence is currently lacking.

Areas of Scientific Research

Ovagen continues to be investigated in laboratory studies involving:

• Liver biology and hepatocyte function
• Gastrointestinal epithelial biology
• Tissue-specific peptide bioregulation
• Cellular regeneration and repair
• Gene expression and epigenetic regulation
• Chromatin remodeling
• Oxidative stress and antioxidant pathways
• Mitochondrial function
• Healthy aging and longevity research
• Cellular protein synthesis
• Metabolic homeostasis
• Inflammatory signaling pathways
• Regenerative medicine
• Molecular bioregulation

These ongoing investigations continue to improve scientific understanding of how ultra-short peptide bioregulators influence tissue-specific cellular function and genomic regulation.

Product Quality

Ovagen 20mg is supplied as a lyophilized (freeze-dried) powder, a formulation commonly used in peptide research because it maximizes molecular stability during transportation and long-term laboratory storage. Lyophilization minimizes degradation caused by moisture while preserving peptide integrity until reconstitution according to laboratory protocols.

High-quality research peptides should undergo comprehensive analytical verification using recognized laboratory techniques such as High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm peptide identity, purity, and batch consistency. These quality-control procedures help ensure reliable, reproducible, and consistent scientific investigations.

This product is intended exclusively for laboratory and scientific research. It is not intended for human consumption, therapeutic use, or veterinary applications.